...
首页> 外文期刊>Drug discovery today >Integration of fragment screening and library design.
【24h】

Integration of fragment screening and library design.

机译:片段筛选和文库设计的集成。

获取原文
获取原文并翻译 | 示例
           

摘要

With more than 10 years of practical experience and theoretical analysis, fragment-based drug discovery (FBDD) has entered the mainstream of the pharmaceutical and biotech industries. An array of biophysical techniques has been used to detect the weak interaction between a fragment and the target. Each technique presents its own requirements regarding the fragment collection and the target; therefore, in order to optimize the potential of FBDD, the nature of the target should be a driving factor for simultaneous development of both the library and the screening technology. A roadmap is now available to guide fragment-to-lead evolution when structural information is available. The next challenge is to apply FBDD to targets for which high-resolution structural information is not available.
机译:基于片段的药物发现(FBDD)拥有10多年的实践经验和理论分析,已进入制药和生物技术行业的主流。已经使用了一系列生物物理技术来检测片段与靶标之间的弱相互作用。每种技术都对片段收集和目标提出了自己的要求。因此,为了优化FBDD的潜力,目标的性质应该是同时开发文库和筛选技术的驱动因素。现在,在可获得结构信息时,可以使用路线图来指导片段到铅的进化。下一个挑战是将FBDD应用于无法获得高分辨率结构信息的目标。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号